Cargando…
Cytoskeletal Remodelling as an Achilles’ Heel for Therapy Resistance in Melanoma
Melanoma is an aggressive skin cancer with a poor prognosis when diagnosed late. MAPK-targeted therapies and immune checkpoint blockers benefit a subset of melanoma patients; however, acquired therapy resistance inevitably arises within a year. In addition, some patients display intrinsic (primary)...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8834185/ https://www.ncbi.nlm.nih.gov/pubmed/35159327 http://dx.doi.org/10.3390/cells11030518 |